Orgenesis Inc. Net Profit Margin

Net Profit Margin of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Profit Margin growth rates and interactive chart. The net profit margin is equal to how much net income or profit is generated as a percentage of revenue. Net profit margin is the ratio of net profits (or net income) to revenues for a company. Net profit margin is typically expressed as a percentage. The net profit margin illustrates how much of each dollar in revenue collected by a company translates into profit.


Highlights and Quick Summary

  • Net Profit Margin for the quarter ending June 29, 2021 was -25.22% (a 982.4% increase compared to previous quarter)
  • Year-over-year quarterly Net Profit Margin decreased by -82.03%
  • Annual Net Profit Margin for 2020 was -1252.06% (a 102.39% increase from previous year)
  • Annual Net Profit Margin for 2019 was -618.65% (a 501.86% increase from previous year)
  • Annual Net Profit Margin for 2018 was -102.79% (a 4.83% increase from previous year)
  • Twelve month Net Profit Margin ending June 29, 2021 was -214.3% (a -52.97% decrease compared to previous quarter)
  • Twelve month trailing Net Profit Margin decreased by -133.76% year-over-year
Trailing Net Profit Margin for the last four month:
29 Jun '21 30 Mar '21 30 Dec '20 29 Sep '20
-214.3% -455.65% 14.51% 634.76%
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Profit Margin of Orgenesis Inc.

Most recent Net Profit Marginof ORGS including historical data for past 10 years.

Interactive Chart of Net Profit Margin of Orgenesis Inc.

Orgenesis Inc. Net Profit Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -25.22% -2.33%
2020 -2005.14% -140.37% -1166.72% 3726.36% -1252.06%
2019 -542.52% -369.24% -459.86% -1983.53% -618.65%
2018 -115.02% -81.38% -65.56% -212.86% -102.79%
2017 -153.79% -108.36% 0.0% -330.78% -122.58%
2016 0.0% -143.0% 0.0% -343.82% -343.82% -173.72%
2015 -150.0%
2014 0.0%
2013 0.0%
2012 0.0%
2011 0.0%

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.